Private Equity

Home Expertise Private Equity

Dynamic advice for agile investors

Our experts are market leaders in private equity transactions, and have represented some of the largest and most high profile domestic and offshore private equity funds, including Pacific Equity Partners, CPE Capital, Advent International, The Riverside Company, The Carlyle Group, CDH, KKR, Pencarrow, Crescent, Apollo, and Primavera.

Our team has significant experience in advising on all aspects of private equity led transactions, including acquisitions, divestments, bolt-ons, financing, and tax issues associated with structuring and fund formation. We have a deep understanding of the key drivers and issues faced by private equity sponsors, and collaborate with experts across our practice to manage any issues that arise from complex, high value private equity transactions.

Our Private Equity experience includes advising:

  • Pacific Equity Partners on:
    • its sale of Manuka Health New Zealand.
    • its acquisition, through its portfolio entity IntelliHUB, of Metrix from Mercury Energy.
    • its acquisition of Manuka Health New Zealand.
    • its acquisition of Academic Colleges Group.
    • its sale of Griffin’s Foods to Universal Robina Corporation.
    • its sale of Tegel to Affinity Equity Partners.
    • its purchase of a 50% interest in SCA Hygiene.
    • its acquisition of Evolution Healthcare.
  • The Riverside Company on:
    • its acquisition of the Hiway Group.
    • its sale of Simcro.
  • CPE Capital in respect of numerous acquisitions and divestments.
  • The Carlyle Group on the New Zealand aspects of its acquisition of Accolade Wines.
  • KKR on its acquisition of MYOB.
  • Allnex (a portfolio company of Advent International) on its $1.05bn acquisition of Nuplex Industries Limited.
  • Pencarrow Private Equity on:
    • its investment in The Collective.
    • its investment in Netlogix.
  • Crescent Capital on:
    • the acquisition, through its portfolio entity New Zealand Panels Group, of the Bestwood and Kopine businesses from Carter Holt Harvey
    • its sale of 'Simply Squeezed' to Frucor Beverages.
    • its sale of Brandlines to DKSH.
    • the New Zealand aspects of the dual track IPO/trade sale process for disposal of the National Hearing Care and Bay Audiology group (ultimately divested to Amplifon in 2010 for AU$460m).
  • Primavera Capital and Shanghai Pharma on their consortium acquisition (via a scheme of arrangement) of Vitaco Holdings.
  • CDH Fund V on its acquisition of an 80% interest in The Better Health Company (otherwise known as ‘Go Healthy’), a substantial New Zealand manufacturer and distributor of natural extracts and dietary supplements.
  • CITIC on its investment in LanzaTech.
  • Oaktree Capital on the restructuring of, and investment in, the Mediaworks Group.
  • Lazard on its sale of PPI New Zealand.
Related People
Related Expertise